secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2024-08-28T23:59:59+00:00
Accession:  0001664710-24-000072
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros CEO to present at three healthcare conferences in September 2024
----------------------------------------------------------------------

- CEO Jasbir Seehra will participate in fireside chats at Morgan Stanley, Wells Fargo, and Cantor conferences.
- Morgan Stanley 22nd Annual Global Healthcare Conference on Sept 4, 2024 at 4:05 pm ET.
- 2024 Wells Fargo Healthcare Conference on Sept 5, 2024 at 10:15 am ET.
- 2024 Cantor Global Healthcare Conference on Sept 19, 2024 at 8:35 am ET.
- Webcast replays will be available on Keros' website for 90 days post-event.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000072/0001664710-24-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000072/kros-20240828.htm
  HTML page:      https://secwatch.observer/filing/0001664710-24-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer